Da32 Life Science Tech Acquisition Corp Cl A (DALS)
Da32 Life Science Tech Acquisition Corp Cl A (DALS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 699 | 1,865 | N/A | N/A | N/A |
| TOTAL | $929 | $2,468 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 202,927 | 200,025 | 0 | 0 | 0 |
| TOTAL | $202,927 | $200,025 | $N/A | $N/A | $N/A |
| Total Assets | $203,856 | $202,493 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1 | 0 | 0 | 0 | 0 |
| Accrued Expenses | 420 | 144 | N/A | N/A | N/A |
| TOTAL | $1,050 | $287 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 207,542 | 205,600 | 0 | 0 | 0 |
| TOTAL | $207,542 | $205,600 | $N/A | $N/A | $N/A |
| Total Liabilities | $208,592 | $205,887 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,650 | 25,650 | N/A | N/A | N/A |
| Common Shares | 1 | 1 | N/A | N/A | N/A |
| Retained earnings | -4,736 | -3,394 | N/A | N/A | N/A |
| TOTAL | $-4,736 | $-3,394 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $203,856 | $202,493 | $0 | $0 | $0 |